2019 Planning Committee

Christine Brezden-Masley, MD, PhD, FRCPC

Associate Professor of Medicine, University of Toronto; Head, Division of Hematology/Oncology, St. Michael's Hospital, Toronto, ON, Canada. President, Canadian Cardiac Oncology Network

founder

Dr. Christine Brezden-Masley is a practicing Medical Oncologist and the Division Head of Hematology / Oncology at St. Michael’s Hospital in Toronto. She is the Co-Director of the Hematology/Oncology Clinical Research Group there. She obtained her PhD in Medical Biophysics at Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is currently an Associate Professor at the University of Toronto and an Associate Scientist at the Li Ka Shing Knowledge Institute.

Read More...

She is the founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a web-based virtual network promoting cancer clinical trials throughout the Toronto Region. She treats both Breast and GI (colorectal and gastric cancers) malignancies and these are the major areas of her clinical research. Her main area of clinical research is cardiotoxicity from cancer therapy and has been the Co-Chair of the Annual Canadian Cardio-Oncology Network meeting, a collaborative national meeting improving cardiac heath in cancer patients. She is currently the President of the Canadian Cardio-Oncology Network. She is active in research, education and has been instrumental in the clinical development of the cancer program at St. Michael’s Hospital.

Negareh Mousavi, MD

Director, Cardio-Oncology Program, McGill University Health Centre, Montreal, QC, Canada

founder

Dr. Negar Mousavi is an assistant professor of medicine at McGill University. Her advanced training was in multi-modality cardiovascular imaging including echocardiography, cardiac MRI, cardiac CT and nuclear cardiology. She is the director of the Cardio-Oncology program at McGill University Health Center. Her research interest is in the utility of advanced imaging techniques for detection of subclinical cancer-therapy related micro- and macrovascular disease.  

Margot Davis, MD SM FRCPC

Clinical Assistant Professor, UBC Cardiology Director, UBC Cardiology-Oncology Program

founder

Margot Davis is a cardiologist at Vancouver General Hospital and St. Paul’s Hospital, a Clinical Assistant Professor at the University of British Columbia, and Director of the UBC Cardiology-Oncology Program. She attended medical school and completed her Internal Medicine residency and Cardiology fellowship at the University of British Columbia. She then completed fellowships in Advanced Heart Failure & Transplant Cardiology and Cardio-Oncology & Cardiac Amyloidosis at Stanford University School of Medicine. She obtained her Master of Science degree in clinical epidemiology at the Harvard School of Public Health.

Read More...

Her research interests are focused on the prevention, diagnosis, and management of heart disease related to cancer therapy, cardiac amyloidosis, and advanced heart failure.

Susan Dent, MD, FRCPC

Professor of Medicine, Associate Director of Breast Cancer Research and Co-Director of Cardio-Oncology, Duke University, Durham, NC, USA; Founder & Past-President, Canadian Cardiac Oncology Network

founder

Dr. Susan Dent is a Professor of Medicine, Associate Director of Breast Cancer Research and Co-Director of Cardio-Oncology at Duke University. She obtained her MD at McMaster University and completed her postgraduate training in Internal Medicine at the University of Ottawa. She continued her training in Medical Oncology in Ottawa, followed by a fellowship year in Clinical Research with the Canadian Cancer Trials Group.

Read More...

Her areas of research interest include breast cancer, and treatment related toxicities with a particular interest in cardiotoxicity. She is the Founder and past-president of the Cardiac Oncology Network, an organization dedicated to improving our understanding of how cancer treatments impact cardiovascular health with the ultimate goal of preventing cardiotoxicity.

Ian Paterson, MD, FRCPC

Cardiologist, Department of Medicine, Division of Cardiology, University of Alberta, Edmonton, AB, Canada

founder

Dr. Ian Paterson is a Professor of Medicine in the Division of Cardiology at the University of Alberta. He completed his Cardiology training and an Echocardiography Fellowship at the McGill University, followed by a Cardiovascular MRI Fellowship at the National Institutes of Health. He is the Academic and Research Director of Cardiovascular Magnetic Resonance at the University of Alberta and Past President of the Canadian Society of Cardiovascular Magnetic Resonance.

Read More...

His research interests include: prevention and treatment of chemotherapy related cardiotoxicity; advanced cardiac imaging (MRI and echo); heart failure; and medical education.

Betty Power, RN, PhD

Retired Professional Educationalist, University of Guelph, Ontario Veterinary College, Toronto, ON, Canada. Board Member, Canadian Cardiac Oncology Network

founder

Dr. Betty is a Professional Educationalist retired from OVC, University of Guelph where she assisted faculty to plan, apply and evaluate the transition from a traditional lecture-based medical model (Sage on the Stage) to an interactive, case-based veterinary medical model (Guide on the Side) of learning and clinical evaluation. Dr. Power has over forty years experience in Education and Administration in Nursing, Medicine, Veterinary Medicine, Health Record Administration and Dental Hygiene.

Read More...

Dr. Betty Power is an active volunteer in Health Science Education (Special Olympics, Can Breast Ca Foundation, Research Ethics Board U of Guelph) and an advocate for funding and prescribing Perjeta (Roche) in Breast Cancer HER-2 disease in progression. Dr. Power currently is a member of the Patient Advisory Board, St. Michael’s Hospital.

Christine Simmons, MD

Medical Oncologist, BC Cancer Agency Vancouver; Clinical Associate Professor, Department of Medicine, University of British Columbia, Vancouver, BC, Canada

founder

Dr. Christine Simmons is a Medical Oncologist at the BCCA Vancouver and Clinical Associate Professor in the Department of Medicine at the University of British Columbia. She completed her residency training in Toronto, and completed a fellowship at Princess Margaret Hospital in Toronto. She also completed a Master’s in Clinical Epidemiology at University of Toronto. She is currently the Chair of Sarcoma Systemic Program for BCCA.

Read More...

She is the former chair of the Locally Advanced Breast Cancer National Consensus group and still plays a key role in that organization. Her academic interests span both teaching and research, and she has held several leadership roles in the Undergraduate Medical Program at UBC in the areas of clinical skills and oncology education. Her research interests are in the areas of health services research in breast cancer and sarcoma. She recently founded the Sarcoma Outcomes Unit at the BC Cancer Agency, and is Founder and Chair of the not‑for‑profit organization, Women in Cancer.

Dinesh Thavendiranathan, MD, MSc SM, FRCPC, FASE

Director, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, Associate Professor of Medicine; University of Toronto, Toronto, ON, Canada

founder

Dr. Paaladinesh Thavendiranathan MD, MSc SM, FRCPC, FASE is a cardiologist at the Toronto General Hospital, University of Toronto. He is an Associate Professor of Medicine and a Clinician Investigator. His training was in advanced cardiovascular imaging and his current clinical practice involves work with cardiac MRI, CT, and echocardiography.

Read More...

He is the Director of the Ted Rogers Program in Cardiotoxicity Prevention which focuses on cardiac toxicity from systemic therapies including cancer therapy. His research focus is in the use of advanced cardiac imaging techniques for detection and management of cardiac toxicity.